Akèy › Distrofi Makilè Viteliform
Etid klinik pou Distrofi Makilè Viteliform ap rekrite nan Etazini
5 etid pou Distrofi Makilè Viteliform ap rekrite patisipan nan sit atravè Etazini.
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07185256Cell Collection to Study Eye Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
1 Day – 120 Years · Tout sèks · Mizajou Sep 22, 2026 · NCT01432847National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
Ap rekriteEtid obsèvasyon
1 Day – 120 Years · Tout sèks · Mizajou Jun 9, 2026 · NCT06491615Inherited Retinal Degenerative Disease Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Tout sèks · Mizajou May 19, 2026 · NCT02435940Study of BEST1 Vitelliform Macular Dystrophy
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 30, 2025 · NCT05809635Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.